Recently, the news that “scientists found that covid-19 treatment new drug stephanine has been patented” has been widely spread, and stephanine related concept stocks have been speculation in the market. Due to an invention patent of stephanine sustained-release preparation, Shenzhen Neptunus Bioengineering Co.Ltd(000078) has also been included in the concept stock of stephanine, and the company’s share price has ushered in a wave of rising market recently.
On the afternoon of May 23, at the annual general meeting of shareholders held in Shenzhen Neptunus Bioengineering Co.Ltd(000078) meeting, Zhang Feng, President of the company, said: “stephanine is an old medicine, and the company only owns the patent right of stephanine sustained-release preparation invention. When stephanine can be fully applied to covid-19 treatment in the future, further scientific experiments and demonstration are needed, and there are still many unknown factors.”
